Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Glioma 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Monoclonal Gammopathy of Undetermined Significance 1 Magnetic Resonance Imaging 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Kidney Neoplasms 1 Hypothyroidism 1 Hyperphagia 1 Hepatic Encephalopathy 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Fentanyl 27 Analgesia 23 Morphine 20 Acupuncture Therapy 18 Surveys and Questionnaires 16 Oxycodone 16 Zoledronic Acid 15 Acetaminophen 14 Therapeutics 13 Radiotherapy 13 Psychiatric Rehabilitation 13 Ketamine 13 Methadone 11 Lidocaine 11 Hydromorphone 11 Bupivacaine 11 nabiximols 10 Ibandronic Acid 10 Ropivacaine 9 Early Intervention, Educational 7 Analgesics, Opioid 7 Saline Solution 6 Music Therapy 6 Cryotherapy 6 Cryosurgery 6 Yoga 5 Water 5 Tapentadol 5 Pregabalin 5 Methods 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Glucose × Clear all

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡